- 201. Cisplatin/Fluorouracil/Irinotecan/Leucovorin Calcium
- (UMLS (NCI) C1328117) =Therapeutic or Preventive Procedure; ;
| - 225. CISTERNAL PUNCTURE
- [ ] (UMLS (ICD9CM) C0195877) =Therapeutic or Preventive Procedure
|
- 202. Cisplatin/Fluorouracil/Oblimersen
- (UMLS (NCI) C1327988) =Therapeutic or Preventive Procedure ;
| - 226. cistron
- [ ] (UMLS (CSP) C0008844) =Gene or Genome ;
|
- 203. Cisplatin/Fluorouracil/Paclitaxel/Pegfilgrastim
- (UMLS (NCI) C1327999) =Therapeutic or Preventive Procedure ;
| - 227. citalopram
- [selective neuronal serotonin reuptake inhibitor and a clinically effective antidepressant with tolerable side effects; effective in reducing ethanol uptake in alcoholics. ( CSP )] (UMLS (CSP) C0008845) =Organic Chemical; Pharmacologic Substance =amine;
[CN600] ANTIDEPRESSANTS;
Propylamines;
serotonin inhibitor;
[CN609] ANTIDEPRESSANTS, OTHER;
=1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Monohydrobromide;
Citalopram 20 MG Oral Tablet;
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Monohydrobromide;
CITALOPRAM 10 MG |
- 204. Cisplatin/Fluoxetine/Gemcitabine
- (UMLS (NCI) C1134649) =Therapeutic or Preventive Procedure
| - 228. Citanest
- (UMLS (NCI) C0591261) =Organic Chemical; Pharmacologic Substance ;
|
- 205. Cisplatin/Gefitinib
- (UMLS (NCI) C1134608) =Therapeutic or Preventive Procedure
| - 229. Citation
- [An extract or quotation from or reference to an authoritative source, e.g. a book or author, used, for example, to support an idea, theory, or argument. ( NCI )] (UMLS (NCI) C0552371) =Intellectual Product ;
|
- 206. Cisplatin/Gefitinib/Gemcitabine
- (UMLS (NCI) C0879545) =Therapeutic or Preventive Procedure ;
| - 230. Citellus
- [ ] (UMLS (CSP) C0037877) =Mammal ;
|
- 207. Cisplatin/Gemcitabine/ISIS 3521
- (UMLS (NCI) C1327905) =Therapeutic or Preventive Procedure ;
| - 231. citizen
- [Citizen of apolitical entity ( HL7V3.0 )] (UMLS (HL7) C0682134) =Population Group =RoleClassRelationshipFormal;
|
- 208. Cisplatin/Gemcitabine/LY293111
- (UMLS (NCI) C1328131) =Therapeutic or Preventive Procedure ;
| - 232. Citizen Potawatomi Nation, Oklahoma
- (UMLS (HL7) C1554266) =Population Group =NativeEntityContiguous;
|
- 209. Cisplatin/Gemcitabine/Paclitaxel
- (UMLS (NCI) C0879597) =Therapeutic or Preventive Procedure
| - 233. Citizenship
- (UMLS (HL7) C0870283) =Idea or Concept ;
=HL7 Vocabulary Version 2.5;
|
- 210. Cisplatin/Gemcitabine/Prinomastat
- (UMLS (NCI) C0879381) =Therapeutic or Preventive Procedure
| - 234. Citramag
- (UMLS (NCI) C0591262) =Organic Chemical; Pharmacologic Substance ;
|
- 211. Cisplatin/Gemcitabine/Tipifarnib
- (UMLS (NCI) C1327900) =Therapeutic or Preventive Procedure ;
| - 235. citrase
- [ ] (UMLS (CSP) C0055813) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 212. Cisplatin/Gemcitabine/Trastuzumab
- (UMLS (NCI) C0935853) =Therapeutic or Preventive Procedure
| - 236. citrate (re) synthase
- [ ] (UMLS (CSP) C0312285) =Amino Acid, Peptide, or Protein; Enzyme
|
- 213. Cisplatin/Imatinib Mesylate/Irinotecan
- (UMLS (NCI) C1327758) =Therapeutic or Preventive Procedure; ;
| - 237. citrate (si) synthase
- [the first enzyme of the Krebs' cycle transfers the 2-carbon unit from acetyl coA to oxaloacetate, forming citrate. ( CSP )] (UMLS (CSP) C0008855) =Amino Acid, Peptide, or Protein; Enzyme =oxoacid lyase;
respiratory enzyme |
- 214. Cisplatin/Irinotecan/SU5416
- (UMLS (NCI) C0879553) =Therapeutic or Preventive Procedure
| - 238. Citrate of Magnesia
- [The citrate salt of the element magnesium with laxative properties. The cathartic action of magnesium cations appears to result, in part, from osmotically mediated water retention, which subsequently stimulates peristalsis. In addition, magnesium ions may also stimulate the activity of nitric oxide (NO) synthase and increase the biosynthesis of the phospholipid proinflammatory mediator platelet activating factor (PAF) in the gut. NO may stimulate intestinal secretion via prostglandin- and cyclic GMP-dependent mechansisms while PAFproduces significant stimulation of colonic secretion and gastrointestinal motility. ( NCI )] (UMLS (NCI) C0126774) =Organic Chemical; Pharmacologic Substance =[TN406] MAGNESIUM;
Organometallic Compound;
2-Hydroxy-1,2,3-propanetricarboxylic Acid;
[GA202] HYPEROSMOTIC LAXATIVES;
CITRATE;
=MAGNESIUM CITRATE LIQUID,ORAL;
BISACODYL 10MG SUPP/BISACODYL 5MG TAB #3/MG CIT 300ML;
MAGNESIUM CITRATE 1.2 OZ;
MAGNESIUM CITRATE 300 ML;
MAGNESIUM CITRATE SOLUTION |
- 215. Cisplatin/Ixabepilone
- (UMLS (NCI) C1327923) =Therapeutic or Preventive Procedure ;
| - 239. citric acid cycle
- [series of reactions involving oxidation of a two-carbon acetyl unit to carbon dioxide and water with the production of high-energy phosphate bonds by means of tricarboxylic acid intermediate. ( CSP )] (UMLS (CSP) C0008858) =Molecular Function ;
=aerobic metabolism;
|
- 216. Cisplatin/Lurtotecan Liposome
- (UMLS (NCI) C0879543) =Therapeutic or Preventive Procedure ;
| - 240. Citrucel
- (UMLS (NCI) C0305648) =Carbohydrate; Pharmacologic Substance
|
- 217. Cisplatin/Mitomycin/Tretinoin/Vinorelbine
- (UMLS (NCI) C0879501) =Therapeutic or Preventive Procedure ;
| - 241. citrulline phosphorylase
- [A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline (CITRULLINE) from CARBAMOYL PHOSPHATE and L-ornithine (ORNITHINE). Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3. ( MSH )] (UMLS (CSP) C0029279) =Amino Acid, Peptide, or Protein; Enzyme ;
=carboxyltransferase/carbamoyltransferase;
|
- 218. Cisplatin/Raltitrexed
- (UMLS (NCI) C0879432) =Therapeutic or Preventive Procedure
| - 242. Citrus Pectin
- [homosaccharidic polymer of sugar acids of fruit that forms gels with sugar at the proper pH. ( CSP )] (UMLS (NCI) C0070203) =Carbohydrate; Pharmacologic Substance =food additive;
Pectins;
plant extract;
hexuronate;
Inactive Ingredient Preparations;
=ORABASE PLAIN PASTE;
Benzocaine 0.2 MG/MG Toothpaste;
KAOPECTOLIN W/PAREGORIC LIQUID;
PECTIN 130 MG;
PECTIN 65 MG;
PECTIN 130 MG/30ML;
PECTIN 260 MG/30ML;
PECTIN 100 MG;
PECTIN CAP/TAB;
PECTIN 142.8 MG/30ML;
PECTIN 194.4 MG/30ML |
- 219. Cisplatin/Rebeccamycin Analog
- (UMLS (NCI) C0879384) Cisplatin/Rebeccamycin Analogue;
=Therapeutic or Preventive Procedure | - 243. citrus stubborn disease agent
- [ ] (UMLS (CSP) C0598912) =Bacterium ;
|
- 220. Cisplatin/S-1
- (UMLS (NCI) C1328128) =Therapeutic or Preventive Procedure ;
| - 244. city
- [A large and densely populated urban area; a city specified in an address. ( NCI )] (UMLS (CSP) C0008848) =Geographic Area ;
|
- 221. Cisplatin/Tirapazamine/Vinorelbine
- (UMLS (NCI) C0879461) =Therapeutic or Preventive Procedure ;
| - 245. city or town
- [The territory of a city, town or other municipality. ( HL7V3.0 )] (UMLS (HL7) C1555315) =Geographic Area =place;
|
- 222. Cisplatin/Tretinoin/Vinorelbine
- (UMLS (NCI) C0879502) =Therapeutic or Preventive Procedure ;
| - 246. city planning
- [Comprehensive planning for the physical development of the city. ( MSH )] (UMLS (CSP) C0008866) =Governmental or Regulatory Activity ;
|
- 223. Cisplatin/UCN-01
- (UMLS (NCI) C0935799) =Therapeutic or Preventive Procedure
| - 247. civil rights
- [Legal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. (from http://www.usccr.gov/ accessed 1/31/2003) ( MSH )] (UMLS (CSP) C0008869) =Idea or Concept ;
|
- 224. Cisterna of the Rough Endoplasmic Reticulum
- (UMLS (NCI) C1180016) =Cell Component ;
| |
home
